FDA Approves Novel Prostate Cancer “Vaccine”
April 30, 2010 by biotechbillboard.com
FDA Approves Novel Prostate Cancer “Vaccine”
The treatment, which works by turning the body’s immune system against invading cancer cells, is called Provenge and is manufactured by Seattle biotech firm Dendreon
Read more on Time Magazine
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!
You must be logged in to post a comment.